Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company	Revenue	Net income ▴	Net margin	Return on equity	Revenue growth	Diluted EPS
VTRS	Viatris Inc Manufacturing · Year ended 2025-12-31 · USD	$14.30B	-$3.51B	-24.6%	-23.9%	-3.0%	-$3.00
PRGO	Perrigo Co PLC Manufacturing · Year ended 2025-12-31 · USD	$4.25B	-$1.43B	-33.5%	-48.6%	-2.8%	-$10.29
INSM	Insmed Inc Manufacturing · Year ended 2025-12-31 · USD	$606.42M	-$1.28B	-210.5%	-172.8%	66.7%	-$6.42
SMMT	Summit Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$1.08B	n/a	-163.9%	n/a	-$1.44
CYTK	Cytokinetics Inc Manufacturing · Year ended 2025-12-31 · USD	$88.04M	-$784.96M	-891.6%	n/a	376.6%	-$6.54
BHVN	Biohaven Ltd. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$738.82M	n/a	n/m	n/a	-$6.86
BBIO	BridgeBio Pharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$502.08M	-$732.94M	-146.0%	n/a	126.3%	-$3.78
SRPT	Sarepta Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.20B	-$713.41M	-32.5%	-62.5%	15.6%	-$7.13
RARE	Ultragenyx Pharmaceutical Inc. Manufacturing · Year ended 2025-12-31 · USD	$673.00M	-$575.00M	-85.4%	n/a	20.2%	-$5.83
DYN	Dyne Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$446.21M	n/a	-45.9%	n/a	-$3.47
AGIO	Agios Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$54.03M	-$412.78M	-764.0%	-34.6%	48.0%	-$7.12
IONS	Ionis Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$943.71M	-$381.39M	-40.4%	-78.0%	33.8%	-$2.38
ZBIO	Zenas BioPharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$10.00M	-$377.74M	n/m	-156.0%	100.0%	-$8.44
VKTX	Viking Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$359.64M	n/a	-56.3%	n/a	-$3.19
JAZZ	Jazz Pharmaceuticals plc Manufacturing · Year ended 2025-12-31 · USD	$4.27B	-$356.15M	-8.3%	-8.2%	4.9%	-$5.84
RCUS	Arcus Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$247.00M	-$353.00M	-142.9%	-55.9%	-4.3%	-$3.29
XENE	Xenon Pharmaceuticals Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.50M	-$345.91M	n/m	-59.5%	n/a	-$4.36
VRDN	Viridian Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$70.85M	-$342.60M	-483.6%	-47.4%	n/m	n/a
COGT	Cogent Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$328.94M	n/a	-51.7%	n/a	-$2.16
PRAX	Praxis Precision Medicines, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$303.27M	n/a	-34.5%	-100.0%	-$13.48
ROIV	Roivant Sciences Ltd. Manufacturing · Year ended 2026-03-31 · USD	$8.26M	-$299.77M	n/m	-6.6%	-71.6%	-$0.54
VERA	Vera Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$299.62M	n/a	-49.6%	n/a	-$4.66
NERV	Minerva Neurosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$293.42M	n/a	n/a	n/a	-$34.67
MDGL	Madrigal Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$958.40M	-$288.28M	-30.1%	-47.8%	432.1%	-$12.85
CMPS	COMPASS Pathways plc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$287.86M	n/a	n/a	n/a	-$3.08
SNDX	Syndax Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$172.35M	-$285.42M	-165.6%	-441.6%	627.8%	-$3.29
KURA	Kura Oncology, Inc. Manufacturing · Year ended 2025-12-31 · USD	$67.48M	-$278.67M	-412.9%	-160.0%	25.2%	-$3.18
LYEL	Lyell Immunopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$36.0K	-$274.45M	n/m	-110.6%	-41.0%	-$16.06
OCUL	Ocular Therapeutix, Inc Manufacturing · Year ended 2025-12-31 · USD	$51.95M	-$265.94M	-511.9%	-40.6%	-18.5%	-$1.42
NRIX	Nurix Therapeutics, Inc. Manufacturing · Year ended 2025-11-30 · USD	$83.98M	-$264.46M	-314.9%	-49.1%	54.0%	-$3.05
PGEN	Precigen, Inc. Manufacturing · Year ended 2025-12-31 · USD	$9.68M	-$250.64M	n/m	n/m	146.7%	-$1.37
PRTA	Prothena Corp Public Ltd Co Manufacturing · Year ended 2025-12-31 · USD	$9.68M	-$244.09M	n/m	-87.0%	-92.8%	-$4.53
ALMS	Alumis Inc. Manufacturing · Year ended 2025-12-31 · USD	$24.05M	-$243.32M	n/m	-80.8%	n/a	-$2.86
ELAN	Elanco Animal Health Inc Manufacturing · Year ended 2025-12-31 · USD	$4.71B	-$232.00M	-4.9%	-3.5%	6.2%	-$0.47
MLTX	MoonLake Immunotherapeutics Manufacturing · Year ended 2025-12-31 · USD	n/a	-$227.32M	n/a	-74.7%	n/a	-$3.53
OPK	Opko Health, Inc. Manufacturing · Year ended 2025-12-31 · USD	$606.88M	-$225.68M	-37.2%	-17.8%	-14.9%	-$0.30
RCKT	Rocket Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$223.12M	n/a	-80.5%	n/a	-$2.01
PHAT	Phathom Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$175.11M	-$221.25M	-126.3%	n/a	216.9%	-$3.03
VNDA	Vanda Pharmaceuticals Inc. Manufacturing · Year ended 2025-12-31 · USD	$216.10M	-$220.47M	-102.0%	-67.4%	8.7%	-$3.74
BCYC	Bicycle Therapeutics PLC Manufacturing · Year ended 2025-12-31 · USD	$72.59M	-$218.96M	-301.7%	-35.9%	105.8%	-$3.16
IMNM	Immunome Inc. Manufacturing · Year ended 2025-12-31 · USD	$6.94M	-$212.39M	n/m	-33.5%	-23.2%	-$2.43
IRON	Disc Medicine, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$212.18M	n/a	-28.7%	n/a	-$6.01
DMRA	Damora Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$209.84M	n/a	-87.3%	n/a	$3.98
VSTM	Verastem, Inc. Manufacturing · Year ended 2025-12-31 · USD	$30.91M	-$209.47M	-677.6%	-366.2%	209.1%	-$3.02
ANNX	Annexon, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$206.69M	n/a	-97.7%	n/a	-$1.34
NUVB	Nuvation Bio Inc. Manufacturing · Year ended 2025-12-31 · USD	$62.90M	-$204.63M	-325.3%	-66.9%	699.0%	-$0.60
WVE	Wave Life Sciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$42.73M	-$204.38M	-478.3%	-39.4%	-60.5%	-$1.21
NAMS	NewAmsterdam Pharma Co N.V. Manufacturing · Year ended 2025-12-31 · USD	$22.50M	-$203.82M	-905.7%	-29.8%	-50.6%	-$1.72
QURE	uniQure N.V. Manufacturing · Year ended 2025-12-31 · USD	$16.10M	-$198.97M	n/m	-100.0%	-40.6%	-$3.46
SVA	Sinovac Biotech Ltd Manufacturing · Year ended 2025-12-31 · USD	$386.01M	-$198.84M	-51.5%	-3.1%	6.8%	-$0.83
RYTM	Rhythm Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$189.76M	-$196.54M	-103.6%	-141.3%	45.8%	-$3.11
KPTI	Karyopharm Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	$146.07M	-$196.04M	-134.2%	n/a	0.6%	-$17.93
AXSM	Axsome Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$638.50M	-$183.17M	-28.7%	-207.5%	65.5%	-$3.68
LNAI	Lunai Bioworks Inc. Manufacturing · Year ended 2025-06-30 · USD	n/a	-$178.01M	n/a	n/a	n/a	-$1.08
ZLAB	Zai Lab Ltd Manufacturing · Year ended 2025-12-31 · USD	$457.18M	-$175.54M	-38.4%	-24.5%	15.0%	-$0.16
SPRY	ARS Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$84.28M	-$171.30M	-203.3%	-149.9%	-5.5%	-$1.74
GOSS	Gossamer Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$48.47M	-$170.37M	-351.5%	n/a	-57.7%	-$0.75
EWTX	Edgewise Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$167.79M	n/a	-32.1%	n/a	-$1.63
AVBP	ArriVent BioPharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$166.31M	n/a	-54.1%	n/a	-$4.32
LRMR	Larimar Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$165.67M	n/a	-212.2%	n/a	n/a
NKTR	Nektar Therapeutics Manufacturing · Year ended 2025-12-31 · USD	$55.23M	-$164.08M	-297.1%	-182.6%	-43.9%	-$9.73
OLMA	Olema Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$162.45M	n/a	-33.9%	n/a	-$1.87
DNTH	Dianthus Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.04M	-$162.34M	n/m	-32.9%	-67.3%	-$4.20
MPLT	MapLight Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$161.15M	n/a	-35.2%	n/a	-$18.56
SMNR	Semnur Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$160.42M	n/a	n/a	n/a	-$0.78
AVIR	Atea Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$158.35M	n/a	-57.5%	n/a	-$1.94
SYRE	Spyre Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$155.20M	n/a	-21.7%	n/a	n/a
MLYS	Mineralys Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$154.65M	n/a	-23.9%	n/a	-$2.29
CBIO	Crescent Biopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$10.84M	-$153.94M	n/m	-75.8%	n/a	n/a
URGN	UroGen Pharma Ltd. Manufacturing · Year ended 2025-12-31 · USD	$109.79M	-$153.49M	-139.8%	n/a	21.4%	n/a
PLRX	Pliant Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$149.34M	n/a	-82.4%	n/a	-$2.43
ABCL	AbCellera Biologics Inc. Manufacturing · Year ended 2025-12-31 · USD	$75.13M	-$146.41M	-194.9%	-15.1%	160.6%	-$0.49
AMLX	Amylyx Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$144.74M	n/a	-47.4%	-100.0%	-$1.53
TRDA	Entrada Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$25.42M	-$143.75M	-565.5%	-47.0%	-87.9%	-$3.47
UPB	Upstream Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.85M	-$143.44M	n/m	-42.2%	20.4%	-$2.66
ADCT	ADC Therapeutics SA Manufacturing · Year ended 2025-12-31 · USD	$81.36M	-$142.62M	-175.3%	n/a	14.9%	-$1.12
GPCR	Structure Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$141.20M	n/a	-9.3%	n/a	-$0.80
BCAX	Bicara Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$137.95M	n/a	-34.4%	n/a	-$2.52
ZNTL	Zentalis Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$137.06M	n/a	-63.4%	-100.0%	-$1.91
BBOT	BridgeBio Oncology Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$134.04M	n/a	-32.6%	n/a	-$4.30
MRVI	Maravai Lifesciences Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$185.74M	-$130.77M	-70.4%	-61.6%	-28.3%	-$0.90
RNAC	Cartesian Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.80M	-$130.30M	n/m	n/a	-92.8%	-$5.02
PTGX	Protagonist Therapeutics, Inc Manufacturing · Year ended 2025-12-31 · USD	$46.02M	-$130.15M	-282.8%	-21.2%	-89.4%	-$2.05
ORIC	Oric Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$129.47M	n/a	-33.7%	n/a	-$1.47
JBIO	Jade Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$127.41M	n/a	-38.3%	n/a	-$3.19
ERAS	Erasca, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$124.55M	n/a	-38.3%	n/a	-$0.44
TNXP	Tonix Pharmaceuticals Holding Corp. Manufacturing · Year ended 2025-12-31 · USD	$13.11M	-$124.02M	-946.2%	-50.6%	29.8%	-$14.57
TYRA	Tyra Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$119.95M	n/a	-46.3%	n/a	-$2.01
SVRA	Savara Inc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$118.84M	n/a	-58.5%	n/a	-$0.53
KRRO	Korro Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$6.39M	-$117.26M	n/m	-228.0%	181.5%	-$12.48
ACET	Adicet Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$116.80M	n/a	-73.4%	n/a	-$16.95
IDYA	IDEAYA Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$218.71M	-$113.70M	-52.0%	-11.1%	n/m	-$1.28
JANX	Janux Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$10.00M	-$113.62M	n/m	-11.9%	-5.6%	-$1.83
RAPP	Rapport Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$111.48M	n/a	-23.0%	n/a	-$2.86
ORKA	Oruka Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$105.43M	n/a	-22.3%	n/a	n/a
CAPR	Capricor Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$105.04M	n/a	-34.4%	-100.0%	-$2.26
NKTX	Nkarta, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$104.08M	n/a	-33.3%	n/a	-$1.41
ELVN	Enliven Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$103.69M	n/a	-22.6%	n/a	-$1.83
SDGR	Schrodinger, Inc. Manufacturing · Year ended 2025-12-31 · USD	$255.87M	-$103.27M	-40.4%	-28.4%	23.3%	-$1.41
CATX	Perspective Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$103.12M	n/a	-49.8%	n/a	-$1.40

Rows per page: 25 50100